No More Guessing: Duke Pediatric Experts Build Unique Foundation to Find the Right Dose for Children
In the Duke Clinical Research Institute, a group of pediatric physician-scientists has built a unique foundation for finding public health answers. Fueled by a deeply ingrained commitment to teamwork and mentorship and a shared ability for recognizing opportunities to advance clinical research, they are having an enormous impact on medical treatments for children — and adults — and influencing public health and student wellness across the country.
A new Duke Cancer Institute research program co-led by Meira Epplein, PhD, and Katharine Garman, MD, brings together physicians, cancer biologists, epidemiologists, and biostatisticians to develop new ways to identify people at increased risk of cancer — specifically stomach cancer in Black community populations — and to “intercept” the disease before it has a chance to become established.
Earlier this summer, Mary E. Klotman, MD, was appointed to a second five-year term as dean of the School of Medicine. In a wide-ranging interview, she looks back at the successes, challenges, and lessons learned during her eventful first term as dean and shares her thoughts on plans for the next five years.
Antoinette Jasmine Charles, a second-year medical student, has already built an impressive record of social justice, activism, and civic service. This summer she was invited to join the White House Health Equity Leaders Roundtable Series, a series of discussions among medical students, clinicians, and policymakers focused on issues including access to care and social determinants of health.